116 related articles for article (PubMed ID: 6288240)
21. Phase II study of tamoxifen in patients with advanced renal cell carcinoma.
Glick JH; Wein A; Torri S; Alavi J; Harris D; Brodovsky H
Cancer Treat Rep; 1980; 64(2-3):343-4. PubMed ID: 7407768
[No Abstract] [Full Text] [Related]
22. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
Bukowski RM; LoBuglio A; McCracken J; Pugh R
Cancer Treat Rep; 1980; 64(12):1387-8. PubMed ID: 7471126
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen: an overview of recent studies in the field of oncology.
Patterson JS; Battersby LA
Cancer Treat Rep; 1980; 64(6-7):775-8. PubMed ID: 7000349
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
25. Murine renal cell carcinoma: a suitable human model.
Murphy GP
Prog Clin Biol Res; 1982; 100():175-206. PubMed ID: 6216486
[TBL] [Abstract][Full Text] [Related]
26. Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma).
Samuels ML; Sullivan P; Howe CD
Cancer; 1968 Sep; 22(3):525-32. PubMed ID: 5673232
[No Abstract] [Full Text] [Related]
27. Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
Lee CP; Patel PM; Selby PJ; Hancock BW; Mak I; Pyle L; James MG; Beirne DA; Steeds S; A'Hern R; Gore ME; Eisen T
J Clin Oncol; 2006 Feb; 24(6):898-903. PubMed ID: 16484699
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of prostatic, corpus uteri and kidney neoplasms (hypernephromas) in general practice].
Obrecht JP; Mayr AC; Nagel G
Schweiz Med Wochenschr; 1973 Oct; 103(41):1414-21. PubMed ID: 4751562
[No Abstract] [Full Text] [Related]
29. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
Todd RF; Garnick MB; Canellos GP
Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
[No Abstract] [Full Text] [Related]
30. Phase II trial of diaziquone in advanced renal adenocarcinoma.
Hansen M; Gallmeier WM; Vermorken J; Holdener E; Hansen HH; Renard J; Rozencweig M
Cancer Treat Rep; 1984; 68(7-8):1055-6. PubMed ID: 6744342
[No Abstract] [Full Text] [Related]
31. The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma.
Kjaer M
Cancer Treat Rev; 1988 Sep; 15(3):195-209. PubMed ID: 2974757
[No Abstract] [Full Text] [Related]
32. Treatment of advanced adenocarcinoma of the kidney with mitolactol: a Southeastern Cancer Study Group Trial.
Brubaker LH; Nelson MO; Birch R; Williams S
Cancer Treat Rep; 1986 Feb; 70(2):305-6. PubMed ID: 3948194
[No Abstract] [Full Text] [Related]
33. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
[TBL] [Abstract][Full Text] [Related]
34. Treatment of advanced adenocarcinoma of the kidney with ICRF-187: a Southeastern Cancer Study Group Trial.
Brubaker LH; Vogel CL; Einhorn LH; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):915-6. PubMed ID: 3087618
[No Abstract] [Full Text] [Related]
35. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Van Echo DA; Markus S; Aisner J; Wiernik PH
Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
[No Abstract] [Full Text] [Related]
36. Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney. A Southwest Oncology Group study.
Taylor SA; Goodman P; Crawford ED; Stuckey WJ; Stephens RL; Gaynor ER
Invest New Drugs; 1992 Apr; 10(1):55-6. PubMed ID: 1607254
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of hexamethylmelamine in murine renal cell carcinoma model.
Williams PD; Burdick J; Murphy GP
Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):399-407. PubMed ID: 4818383
[No Abstract] [Full Text] [Related]
38. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
[TBL] [Abstract][Full Text] [Related]
39. The role of embolization and nephrectomy in the treatment of metastatic renal carcinoma.
Swanson DA; Wallace S; Johnson DE
Urol Clin North Am; 1980 Oct; 7(3):719-30. PubMed ID: 7456183
[No Abstract] [Full Text] [Related]
40. [Hormonal therapy of adenocarcinoma of the kidney].
Barsel' VA; Volin EM; Parfenova LK; Orlova RS
Urol Nefrol (Mosk); 1973; 38(1):62-3. PubMed ID: 4693767
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
